PSPhilip A. Sapp

Philip A. Sapp

*This is an algorithmically generated author record based on publicly available information.

Philip A. Sapp has a total of 69 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Absorption kinetics of vitamins and minerals from a novel nutritional product in physically active adults: a randomized, double-blind, placebo-controlled crossover trial

    by Philip A. Sapp, Jeremy R. Townsend, Trevor O. Kirby, Caitlyn G. Edwards, Michael B. La Monica, Tim N. Ziegenfuss, Matthew J. Vergne, Wendell S. Akers, Ralph Esposito

    Background/objectives: Nutrient interactions in multi-ingredient supplements may influence micronutrient absorption and bioavailability, yet pharmacokinetic data exploring these interactions remains generally limited. This clinical trial assessed the acute absorption phase of key micronutrients in AG1, a comprehensive nutritional supplement containing vitamins, minerals, probiotics, and phytochemicals. Methods: In a randomized, double-blind, placebo-controlled crossover trial 16 healthy adults (8 males and 8 females) consumed a single serving (13 g) of AG1 or a taste- and appearance-matched placebo mixed in water, following a 10-h overnight fast. Each condition was separated by a 1-week washout period. Blood samples were collected 0 (baseline), 30, 60, 90, 120, 180, 240, 360, and 480 min post-ingestion. Plasma concentrations of folate, calcium, zinc, vitamin C, biotin, nicotinamide, pyridoxine, riboflavin, thiamine, and hesperidin were measured. The absorption phase was generally characterized using area under the curve (AUC 0-480 min ), C max , and T max . Safety and tolerability were assessed throughout the study. Statistical analysis included repeated-measures ANOVA and paired t-tests. Results: AG1 significantly increased AUC 0-480 min values ( p < 0.05) for all measured nutrients except pyridoxine which revealed a weak trend ( p = 0.1205). Both AG1 and placebo were well tolerated, with no serious adverse events reported. Conclusion: Acute consumption of AG1 resulted in measurable increases in circulating levels of most of the tested micronutrients, indicating effective absorption. These findings suggest that AG1 may influence nutrient status in healthy adults. Clinical trial registration: Clinicaltrials.gov , identifier NCT06316700.

  • Open Access

    Absorption Kinetics of Vitamins and Minerals from a Novel Nutritional Product in Healthy Adults: A Randomized, Double Blind, Placebo-Controlled Crossover Trial

    by Philip A. Sapp, Jeremy R. Townsend, Trevor O. Kirby, Caitlyn G. Edwards, Michael B. La Monica, Tim N. Ziegenfuss, Matthew J. Vernge, Wendell S. Akers, Ralph Esposito

    Background/Objectives: Nutrient interactions in multi-ingredient supplements may influence absorption and bioavailability, yet pharmacokinetic data in this context remains limited. This clinical trial assessed the post-prandial absorption kinetics of key micronutrients in AG1, a comprehensive supplement containing vitamins, minerals, probiotics, and phytonutrients. Methods: In a randomized, double-blind, placebo-controlled crossover trial 16 healthy adults (8 males and 8 females) consumed a single serving (13g) of AG1 or a taste- and appearance-matched placebo mixed in water, following a 10-hour overnight fast. Each condition was separated by a 1-week washout. Blood samples were collected pre-consumption and at 30, 60, 90, 120, 180, 240, 360, and 480 minutes post-ingestion. Plasma concentrations of folate, calcium, zinc, vitamin C, biotin, nicotinamide, pyridoxine, riboflavin, thiamin, and hesperidin were measured. Area under the curve (AUC 0-480 min ) was used to assess nutrient absorption. Safety and tolerability were assessed throughout the study. Statistical analysis included repeated measures ANOVA and paired t-tests. Results: AG1 significantly increased AUC 0-480 min values (p<0.05) for all measured nutrients except pyridoxine which revealed a strong trend (p = 0.075) and hesperidin (p = 0.224). Both AG1 and placebo were well tolerated, with no serious adverse events reported. Conclusions: Acute consumption of AG1 resulted in measurable increases in circulating levels of most of the tested micronutrients, indicating effective absorption and bioavailability. These findings support the potential of AG1 to contribute meaningfully to nutritional status and overall health.

  • Open Access

    Changes in the fecal polar metabolome due to AG1 supplementation in the SHIME® model: A proof of principle study

    by Trevor O. Kirby, Philip A. Sapp, Jeremy R. Townsend, Marlies Govaert, Cindy Duysburgh, Massimo Marzorati, Tess M. Marshall, Ralph Esposito


  • Open Access

    AG1®, a Novel Synbiotic, Maintains Gut Barrier Function following Inflammatory Challenge in a Caco-2/THP1-Blue™ Co-Culture Model

    by Philip A. Sapp, Jeremy R. Townsend, Trevor O. Kirby, Marlies Govaert, Cindy Duysburgh, Lynn Verstrepen, Massimo Marzorati, Tess M. Marshall, Ralph Esposito

    Nutritional interventions to reduce gastrointestinal (GI) permeability are of significant interest to physically active adults and those experiencing chronic health conditions. This in vitro study was designed to assess the impact of AG1, a novel synbiotic, on GI permeability following an inflammatory challenge. Interventions [AG1 (vitamins/minerals, pre-/probiotics, and phytonutrients) and control (control medium)] were fed separately into a human GI tract model (stomach, small intestine, and colon). In the colonic phase, the GI contents were combined with fecal inocula from three healthy human donors. GI permeability was evaluated with transepithelial electrical resistance (TEER) in a Caco-2 (apical)/THP1-Blue™ (basolateral) co-culture model. The apical side received sodium butyrate (positive control) or Caco-2 complete medium (negative control) during baseline testing. In the 24 h experiment, the apical side received colonic simulation isolates from the GI model, and the basolateral side was treated with Caco-2 complete medium, then 6 h treatment with lipopolysaccharide. TEER was assessed at 0 h and 24 h, and inflammatory markers were measured at 30 h in triplicate. Paired samples t-tests were used to evaluate endpoint mean difference (MD) for AG1 vs. control. TEER was higher for AG1 (mean ± SD: 99.89 ± 1.32%) vs. control (mean ± SD: 92.87 ± 1.22%) following activated THP1-induced damage [MD: 7.0% (p < 0.05)]. AG1 maintained TEER similar to the level of the negative control [−0.1% (p = 0.02)]. No differences in inflammatory markers were observed. These in vitro data suggest that acute supplementation with AG1 might stimulate protective effects on GI permeability. These changes may be driven by SCFA production due to the pre-/probiotic properties of AG1, but more research is needed.


  • Open Access

    A Mediterranean Dietary Pattern Is Associated with Greater Participation in Physical Activity and Better Health-Related Quality of Life among Students and Professors at the Melilla Campus (University of Granada)

    by María López-Olivares, Philip Sapp, Terrence M. Riley, Penny M. Kris-Etherton, Carmen Enrique-Mirón, Teresa Nestares, Kristin M. Davis

    The objective of this study was to assess Mediterranean diet (MD) scores (i.e., alignment with a MD pattern) among students and professors, in addition to assessing how adherence to the MD was associated with other lifestyle behaviors. A cross-sectional observational study was conducted with a sample of 127 university professors and 272 students of the Melilla Campus at the University of Granada (Spain). Students were more physically active than professors (mean difference = 1058 METs, p < 0.001) and reported lower negative affect (NA; mean difference = −1.70, p < 0.001) whereas professors reported nominally better perceived mental health. For the total sample, the physical health component (β = 0.03, p = 0.03) and physical activity (β = 0.0001, p = 0.01) were significantly associated with higher MD scores. Health behaviors, including MD scores and physical activity, were suboptimal among both students and professors. The results suggest that a dietary pattern reflective of the MD is positively associated with both physical and mental health outcomes among students and professors, though the direction of the associations remains to be clarified.


  • Top Cited Papers
    Open Access

    Diet-derived and diet-related endogenously produced palmitic acid: Effects on metabolic regulation and cardiovascular disease risk

    by Carmen E. Annevelink, Philip A. Sapp, Kristina S. Petersen, Greg C. Shearer, Penny M. Kris-Etherton


  • Effects of Nutrients on the Control of Blood Lipids

    by Philip A. Sapp, Kristina S. Petersen, Penny M. Kris-Etherton

  • Open Access

    Effects of Nut Consumption on Blood Lipids and Lipoproteins: A Comprehensive Literature Update

    by Marta Guasch-Ferré, Anne-Julie Tessier, Kristina S. Petersen, Philip A. Sapp, Linda C. Tapsell, Jordi Salas-Salvadó, Emilio Ros, Penny M. Kris-Etherton

    In the present review, we provide a comprehensive narrative overview of the current knowledge on the effects of total and specific types of nut consumption (excluding nut oil) on blood lipids and lipoproteins. We identified a total of 19 systematic reviews and meta-analyses of randomized controlled trials (RCTs) that were available in PubMed from the inception date to November 2022. A consistent beneficial effect of most nuts, namely total nuts and tree nuts, including walnuts, almonds, cashews, peanuts, and pistachios, has been reported across meta-analyses in decreasing total cholesterol (mean difference, MD, −0.09 to −0.28 mmol/L), LDL-cholesterol (MD, −0.09 to −0.26 mmol/L), and triglycerides (MD, −0.05 to −0.17 mmol/L). However, no effects on HDL-cholesterol have been uncovered. Preliminary evidence indicates that adding nuts into the regular diet reduces blood levels of apolipoprotein B and improves HDL function. There is also evidence that nuts dose-dependently improve lipids and lipoproteins. Sex, age, or nut processing are not effect modifiers, while a lower BMI and higher baseline lipid concentrations enhance blood lipid/lipoprotein responses. While research is still emerging, the evidence thus far indicates that nut-enriched diets are associated with a reduced number of total LDL particles and small, dense LDL particles. In conclusion, evidence from clinical trials has shown that the consumption of total and specific nuts improves blood lipid profiles by multiple mechanisms. Future directions in this field should include more lipoprotein particle, apolipoprotein B, and HDL function studies.


  • Open Access

    The Dynamic Interplay of Healthy Lifestyle Behaviors for Cardiovascular Health

    by Penny M. Kris-Etherton, Philip A. Sapp, Terrance M. Riley, Kristin M. Davis, Tricia Hart, Olivia Lawler

    Purpose of Review: The recent rise in cardiovascular disease (CVD) deaths in the USA has sparked interest in identifying and implementing effective strategies to reverse this trend. Healthy lifestyle behaviors (i.e., healthy diet, regular physical activity, achieve and maintain a healthy weight, avoid tobacco exposure, good quality sleep, avoiding and managing stress) are the cornerstone for CVD prevention. Recent Findings: Achieving all of these behaviors significantly benefits heart health; however, even small changes lower CVD risk. Moreover, there is interplay among healthy lifestyle behaviors where changing one may result in concomitant changes in another behavior. In contrast, the presence of one or more unhealthy lifestyle behaviors may attenuate changing another lifestyle behavior(s) (poor diet, inadequate physical activity, overweight/obesity, poor sleep quality, tobacco exposure, and poor stress management). Summary: It is important to assess all of these lifestyle behaviors with patients to plan an intervention program that is best positioned for adherence.


  • Open Access

    Peanuts as a nighttime snack enrich butyrate-producing bacteria compared to an isocaloric lower-fat higher-carbohydrate snack in adults with elevated fasting glucose: A randomized crossover trial

    by Philip A. Sapp, Penny M. Kris-Etherton, Elke A. Arnesen, Jeremy R. Chen See, Regina Lamendella, Kristina S. Petersen